Precirix and IFE sign clinical trial manufacturing agreementClinical Trial Manufacturing Agreement • September 13th, 2021
Contract Type FiledSeptember 13th, 2021Brussels, Belgium and Kjeller, Norway, 13 September 2021 – Precirix NV, a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and the Institute for Energy Technology (IFE), a manufacturer of radiopharmaceutical products based in Norway, today announced an agreement for the supply of Precirix’ radiopharmaceuticals in Europe.